The Colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information
2010

Colorectal Cancer Transcriptome Study

Sample size: 28 publication Evidence: high

Author Information

Author(s): Allen Wendy L, Jithesh Puthen V, Oliver Gavin R, Proutski Irina, Longley Daniel B, Lenz Heinz-Josef, Proutski Vitali, Harkin Paul, Johnston Patrick G

Primary Institution: Centre for Cancer Research and Cell Biology, Queen's University Belfast

Hypothesis

The study aims to compare the effectiveness of a disease-specific transcriptome-based microarray with a generic microarray in identifying predictive markers for colorectal cancer treatment response.

Conclusion

The disease-specific transcriptome-based microarray outperformed the generic microarray in detecting relevant transcripts and pathways related to colorectal cancer.

Supporting Evidence

  • The disease-specific microarray detected more differentially expressed probesets than the generic microarray.
  • Pathway analysis revealed that the disease-specific microarray identified more biologically relevant pathways.
  • Many transcripts were found in sense:antisense pairs, suggesting potential regulatory roles.

Takeaway

This study looked at how well a special test for colorectal cancer works compared to a regular test, finding that the special test is better at finding important information.

Methodology

DNA microarray profiling was performed on colorectal cancer cell lines and patient biopsies using two different microarray platforms.

Limitations

The study was based on a single cell line model, which may not fully represent the diversity of colorectal cancer.

Participant Demographics

Patients with metastatic colorectal cancer undergoing treatment.

Statistical Information

P-Value

0.0032

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-10-687

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication